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Abstract
To progress the fields of tissue engineering (TE) and regenerative medicine, development
of quantitative methods for non-invasive three dimensional characterization of engineered
constructs (i.e. cells/tissue combined with scaffolds) becomes essential. In this study, we
have defined the most optimal staining conditions for contrast-enhanced nanofocus com-
puted tomography for three dimensional visualization and quantitative analysis of in vitro
engineered neo-tissue (i.e. extracellular matrix containing cells) in perfusion bioreactor-
developed Ti6Al4V constructs. A fractional factorial ‘design of experiments’ approach was
used to elucidate the influence of the staining time and concentration of two contrast
agents (Hexabrix and phosphotungstic acid) and the neo-tissue volume on the image con-
trast and dataset quality. Additionally, the neo-tissue shrinkage that was induced by phos-
photungstic acid staining was quantified to determine the operating window within which
this contrast agent can be accurately applied. For Hexabrix the staining concentration was
the main parameter influencing image contrast and dataset quality. Using phosphotungstic
acid the staining concentration had a significant influence on the image contrast while both
staining concentration and neo-tissue volume had an influence on the dataset quality. The
use of high concentrations of phosphotungstic acid did however introduce significant
shrinkage of the neo-tissue indicating that, despite sub-optimal image contrast, low con-
centrations of this staining agent should be used to enable quantitative analysis. To con-
clude, design of experiments allowed us to define the most optimal staining conditions for
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contrast-enhanced nanofocus computed tomography to be used as a routine screening
tool of neo-tissue formation in Ti6Al4V constructs, transforming it into a robust three dimen-
sional quality control methodology.
Introduction
The field of tissue engineering (TE) is evolving towards the development of complex, three-di-
mensional (3D) constructs (i.e. cells/tissue combined with scaffold) to mediate the repair of se-
vere defects. In order to facilitate the successful clinical implementation of these constructs an
in-depth understanding of how they develop as well as the optimization of the developed pro-
cedures and the availability of robust 3D quality assessment tools becomes essential.
Currently, the standard technique for evaluating tissue formation is histological sectioning.
It has a high discriminative power, both on tissue and cellular level. However, it shows limited
potential for quantifying 3D tissue formation as it is destructive and costly in terms of time and
resources. Most importantly, in standard settings it only allows assessment of tissue distribu-
tion in 2D, with loss of information due to a restricted sectioning orientation and with limited
depth resolution [1–3]. Other standard techniques to assess the quality of a construct are Live/
Dead, DNA content (providing cell number estimation), histology and weight measurements.
Although Live/Dead staining gives additional important information concerning cell state, it
has limitations for internal, 3D visualization of tissue formation in a construct. Both DNA con-
tent and weight measurements are bulk measurement techniques not providing spatial infor-
mation. Techniques such as confocal or multiphoton microscopy offer a potential for 3D
visualization of cells and tissues. However limited depth resolution (~300μm) and limited op-
tions for detailed quantification hinders their performance when clinically relevant sized or
opaque samples are to be analyzed. Ultrasound and magnetic resonance imaging could obtain
significantly higher imaging depths, but limitations in the spatial resolution result in significant
restrictions for quantitative 3D analysis. Therefore, there is a need for more advanced, quanti-
tative 3D imaging techniques [4].
Recent advances in 3D imaging techniques and image analysis have demonstrated the po-
tential of the currently applied methods and their limitations for accurate analysis. In particular
X-ray micro and nanofocus computed tomography (micro and nanoCT) have been frequently
applied as 3D quantitative imaging techniques to assess mineralized skeletal tissues [5, 6].
However, because of their low X-ray attenuation, soft tissue contrast is inherently poor in ab-
sorption mode imaging. Phase contrast imaging could be a solution [7, 8]. Due to the electro-
magnetic properties of the X-rays, a phase shift of the waves can be induced as a result of
differences in the refractive index of different materials while passing through an object. Taking
this phase shift into account, the contrast sensitivity will be increased, which is especially for
low absorbing materials an important benefit. As this technology requires sophisticated X-ray
optics and preferably monochromatic X-rays, it is mostly available using synchrotron radiation
[9], although recently also desktop CT devices allowing phase contrast imaging have become
available [10, 11].
A recent shift in micro- and nanoCT imaging focuses on the use of X-ray opaque contrast
agents for visualizing soft tissues, such as cartilage [12–15], blood vessels [16–18] and connec-
tive tissues [19, 20]. Specifically in the case of neo-tissues (cells and extracellular matrix), we
have shown proof-of-concept of contrast-enhanced nanoCT (CE-nanoCT) for the 3D visuali-
zation and quantification of neo-tissue within constructs formed in bioreactor cultures [21].
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Two tissue-specific contrast agents were used to stain the neo-tissue, i.e. Hexabrix and phos-
photungstic acid (PTA). As opposed to the standard techniques mentioned earlier, it was
shown that CE-nanoCT could allow 3D qualitative and quantitative structural and spatial as-
sessment of the in vitro engineered neo-tissue, created during static and bioreactor cell cultur-
ing in titanium alloy scaffolds, revealing 3D neo-tissue distribution.
Although this study indicated the potential of CE-nanoCT, the staining conditions, which
were based on preliminary internal experiments [14, 15], resulted in datasets with sub-optimal
image quality. This was due to limited contrast in combination with scaffold-induced imaging
artifacts, such as beam hardening and streaks. Although extensive image processing enabled
quantitative interpretation of the datasets, no automated image analysis was possible yet; this
posed considerable limitations to the proposed methodology. A recent publication that as-
sessed several contrast agents for CE-CT indicated the necessity to optimize the staining pa-
rameters for obtaining quantitative datasets. It was demonstrated that for the same staining
conditions each contrast agent displayed agent-specific contrast enhancement levels and pene-
tration depth, while the sample size further affected its performance [22].
An additional concern for the use of contrast agents is their potential to influence the integ-
rity of the stained tissue. Iodine potassium iodide (I2KI) was shown to cause substantial soft
tissue shrinkage dependent on the concentration, staining time and tissue structure/composi-
tion [23]. Also PTA was shown to introduce shrinkage of brain and muscle tissue, although in
a lesser extent than I2KI [24]. For some studies, the compositional information of the soft tis-
sues in the sample, only obtainable by the staining, was most important [25–27], although
structural tissue alterations due to dehydration or staining were noticed [25]. However, when
aiming at using the CE-CT data for morphometric and volumetric analyses, the degree of spec-
imen shrinkage, and potential deformation, is an important consideration.
In the current study, we applied a ‘Design of Experiments’ (DoE) approach, a statistical
method for planning experiments, for a multiparametric investigation of the influence of stain-
ing parameters (staining time and concentration) and neo-tissue volume on (i) image quality
(i.e. image contrast), (ii) dataset quality (i.e. potential for quantitative interpretation of the ob-
tained datasets) and (iii) tissue integrity (only for PTA). Based on the DoE outcome, optimum
staining conditions for both contrast agents were selected. For these staining conditions, we
were able to develop an automated, user-independent and highly quantitative image processing
and analysis procedure for morphometric analysis of neo-tissue within the constructs. As a re-
sult, CE-nanoCT was optimized for routine screening of the neo-tissue formation in TE con-
structs transforming it to a robust quality control methodology.
Materials and Methods
TE constructs
Ti6Al4V based constructs. To evaluate the influence of the staining parameters of the
contrast agents (staining time and concentration) and neo-tissue volume on the image quality,
dataset quality and tissue integrity, selective laser melted porous cylindrical 3D Ti6Al4V scaf-
folds with a height of 6mm and a diameter of 6mm were used. The design and production of
the Ti6Al4V scaffolds is described in detail in Ref. [28]. Human periosteal derived cells
(hPDCs) [29] were seeded as described before using a static drop-seeding protocol [30].
In order to generate constructs with different amounts of neo-tissue they were subsequently
cultured in a static setup for 3 weeks (low volumes of neo-tissue) or in an in-house developed
perfusion bioreactor system for 1 to 3 weeks (respectively medium and high volumes of neo-tis-
sue) as described earlier [21, 30]. For all conditions the constructs were cultured in growth me-
dium (Dulbecco’s modified Eagle’s medium with high-glucose (Life Technologies) containing
Multifactorial Optimization of CE-CT to Quantify Neo-Tissue Formation
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10% foetal bovine serum (FBS, Gibco), 1% sodium pyruvate (Life Technologies) and 1% antibi-
otic—antimycotic (100 units/mL penicillin, 100 mg/mL streptomycin, and 0.25 mg/mL ampho-
tericin B; Life Technologies)), which was refreshed every two days. For the perfusion bioreactor
system a flow rate of 1 ml/min was used.
PCL based constructs. To assess the effect of the different contrast agents on the tissue in-
tegrity, we used porous cylindrical polycaprolactone (PCL) scaffolds with a height of 3 mm and
a diameter of 6 mm. PCL scaffolds were produced using the BioscaffolderVR device (Sys-Eng,
Germany). The pressure was maintained at 5 bars and the temperature was set to 120°C. The
selected overlay pattern was 0–90°, the anticipated strut diameter was 100 μm and the antici-
pated pore size 200 μm. The scaffolds were designed in Inventor while PrimCam (Sys-Eng,
Germany) was used to create the final structure [31–33]. Also the PCL scaffolds were seeded
with hPDCs using a static drop-seeding protocol. The PCL based constructs were cultured
using the same operating conditions in the perfusion bioreactor system as for the Ti6Al4V
based constructs, but for a period of 2 weeks.
Contrast-enhanced nanofocus CT (CE-nanoCT). After static or dynamic culture, the TE
constructs were rinsed with 1 ml phosphate buffered saline (PBS) and transferred to a 4% para-
formaldehyde solution (Sigma) for 2 hours to fixate the neo-tissue. The TE constructs were
stored in PBS prior to CE-nanoCT scanning. Two contrast agents were used, namely Hexabrix
320 (Guerbet Nederland B.V) and phosphotungstic acid (PTA—VWR International). Hexab-
rix, containing the negatively charged ioxaglate, is an equilibrium contrast agent staining all
non-negatively charged tissues. PTA on the other hand is known to specifically bind to various
components of the connective tissue such as collagen and fibrin [21]. The nanoCT system used
was a Phoenix NanoTom S (GE Measurement and Control Solutions).
Ti6Al4V constructs. For the Ti6Al4V constructs, different concentrations and staining
times of both contrast agents were used according to a 3-level 3-parameter fractional factorial
design as shown in Table 1. TE constructs were initially stained and scanned with Hexabrix,
after which they were rinsed 3 times in PBS overnight to remove all Hexabrix traces prior to
subsequent staining. The same constructs were then stained with PTA and scanned again. As
after removal from the liquid prior to scanning, remnants of the staining solution could be
present at locations where there is no neo-tissue, and thus could influence the visualization of
the neo-tissue, samples were dried for 15 minutes on a paper tissue at room temperature for
both contrast agents [21].
For scanning the Ti6Al4V-based TE constructs, the nanoCT was equipped with a tungsten
target, and was operated at a voltage of 90 kV and a current of 170 μA. A 1 mm filter of alumi-
num and 1 mm of copper was used to reduce beam hardening and metal artifacts as much as
Table 1. The experimental conditions to be evaluated for the 3-level, 3-parameter fractional factorial
design.
Neo-tissue volume Staining time Concentration
3 weeks static (Low) 120 min 60% Hex—7.5% PTA
3 weeks static (Low) 240 min 40% Hex—5% PTA
3 weeks static (Low) 30 min 20% Hex—2.5% PTA
1 week perfusion (Mid) 120 min 40% Hex—5% PTA
1 week perfusion (Mid) 240 min 20% Hex—2.5% PTA
1 week perfusion (Mid) 30 min 60% Hex—7.5% PTA
3 weeks perfusion (High) 120 min 20% Hex—2.5% PTA
3 weeks perfusion (High) 240 min 60% Hex—7.5% PTA
3 weeks perfusion (High) 30 min 40% Hex—5% PTA
doi:10.1371/journal.pone.0130227.t001
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possible during scanning. The exposure time was 500 ms and 2400 radiographic images were
acquired in fast scan mode (frame averaging of 1 and image skip of 0) resulting in a scanning
time of 20 minutes per sample. The scanning time was kept low to allow routine screening and
eliminate sample movement during scanning. The reconstructed images had an isotropic voxel
size of 3.75 μm. A beam hardening correction of 9 and a Gaussian filter of 6 was applied during
reconstruction [Datos|x, GE Measurement and Control Solutions, Germany].
PCL based constructs. To determine the effect of the contrast agents on the neo-tissue
integrity, a comparison between the datasets of constructs with and without staining was
made. Therefore, the PCL based TE constructs were consecutively scanned (1) without con-
trast agent, (2) with Hexabrix, (3) with PTA, (4) again with Hexabrix and finally (5) without
contrast agent.
For scanning the PCL-based TE constructs, a 1 mm aluminum filter was used and the tung-
sten target was operated at a voltage of 60 kV and 220 μA. All other scanning as well as the re-
construction parameters were similar to what was used for the Ti6Al4V based constructs.
DoE analysis
To determine the influence of the concentration and staining time of the contrast agents as
well as the neo-tissue volume (further referred to as DoE parameters) on the image quality,
dataset quality and tissue integrity, a DoE approach was used. This statistical method for plan-
ning experiments enables to study the influence of various parameters with minimal required
experimental input but resulting in the required objective conclusions [34]. Fig 1 and Table 1
show the different combinations of the DoE parameters, selected in a randomized manner by
the statistics software JMP (SAS, Cary, USA), that were evaluated according to a 3-level, 3-fac-
tor fractional factorial design. Based on previous experiments [21] and a preliminary range
screening, the three levels were selected for each parameter. Ti6Al4V based TE constructs cul-
tured for 3 weeks in the static system represented the low neo-tissue volume level, 1 week in
the perfusion bioreactor system the mid-level and 3 weeks in the perfusion bioreactor the high
level [21, 30]. For each condition, 3 samples were evaluated.
DoE was applied to obtain statistically sound and objective conclusions on the magnitude
and the importance of the main effects of the investigated factors (i.e. volume of neo-tissue,
contrast agent concentration and staining time) on (i) the normalized contrast of the stained
neo-tissue (i.e. contrast of the stained neo-tissue compared to the background and scaffold),
(ii) the dataset quality (i.e. the amount of slices with a mismatch between the stained and the
binarized neo-tissue fraction) and (iii) the tissue integrity (i.e. difference between the Hexabrix
and PTA stained neo-tissue). The Pareto charts display the absolute values of the standardized
effects and have a reference line for p = 0.05. Any effect that extends beyond this reference line
is a significant effect. The more the effect extends the reference line, the more important the
effect is.
Influence of the DoE parameters on the image contrast. To quantify the contrast of the
stained neo-tissue compared to the background and scaffold, a greyscale histogram was plotted
along an arbitrary line through the background, neo-tissue and scaffold (Fig 2A) using Data-
Viewer (Bruker MicroCT, Belgium). The normalized contrast was then calculated according to
Eq 1 (Fig 2B).
B
ðAþ BÞ ¼ normalizedcontrast ð1Þ
where A is the average greyscale difference between the stained neo-tissue and the scaffold, and
B is the average greyscale difference between the background and the stained neo-tissue. A + B
Multifactorial Optimization of CE-CT to Quantify Neo-Tissue Formation
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is thus the average greyscale difference between the background and the scaffold. The calculat-
ed averages did not take into account the transition grey-scale values between the different
phases. We only considered the grey-scale values within the range that did not deviate too
much from the average value (i.e. plateau region). The thresholds to define the range for which
Fig 1. Design space for the DoE, showing the three levels of the three parameters. For the
concentration, the top value is for Hexabrix staining and the bottom value for PTA staining. The grey dots
indicate the experimental conditions for the fractional factorial design (n = 3).
doi:10.1371/journal.pone.0130227.g001
Fig 2. Normalized image contrast quantification of the stained neo-tissue compared to the
background and scaffold. (A) A representative transaxial cross-section of a Hexabrix (60%) stained
construct with a mid-level of neo-tissue volume. Scale bar is 1 mm. (B) The greyscale histogram through the
red line indicated in (A), used to quantify the contrast of the stained neo-tissue compared to the background
and scaffold. ‘A’ is the average greyscale difference between the stained neo-tissue and the scaffold, and ‘B’
is the average greyscale difference between the background and the stained neo-tissue.
doi:10.1371/journal.pone.0130227.g002
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the average was determined, were set at the grey-scale values that decreased below (or increased
above) the lowest/highest value within the plateau region.
Influence of the DoE parameters on the dataset quality. The fraction of images contain-
ing a mismatch between the stained and binarized neo-tissue fraction, being a measure for the
potential for quantitative interpretation or the dataset quality, was determined as a second
input for the DoE. To obtain the binarized neo-tissue fraction multi-level Otsu segmentation
was applied. This algorithm, which is a histogram-based methodology that maximizes the vari-
ance between the different classes in the greyscale image [35], was performed on each individu-
al 2D slice using CTAn (Bruker micro-CT, Belgium). Segmentation classes corresponding to
the neo-tissue were subsequently binarized. The number of levels for the Otsu segmentation
had a strong influence on the mismatch, because depending on the neo-tissue volume and/or
contrast, the background noise and artifacts could be assigned to different segmentation clas-
ses. Therefore, the optimal number of Otsu-levels was determined for each contrast agent
based on the datasets obtained with low, mid and high levels for each DoE parameter. The opti-
mized number of Otsu levels per contrast agent was then used on the datasets of all the DoE
conditions to determine the dataset quality.
To calculate the mismatch between the stained neo-tissue and the binarized neo-tissue frac-
tion (Fig 3A and 3B), a differential overlay of both was made (Fig 3C). Binarized differential
overlays were subsequently analyzed for the ‘mismatched neo-tissue’ fraction and histograms
that show the area of the mismatched fraction were generated (Fig 3D). Based on these
Fig 3. Mismatch between the stained and binarized neo-tissue fraction as a measure for the dataset
quality. (A, B) A raw (left), 2-level segmented (middle) and binarized image (right) cross-section of a TE
construct with a high level of neo-tissue volume after 120 min staining with 20% Hexabrix located in the
middle of zone V (A) and zone VI (B). Zoning depicted in (C)—green numbers indicates zones without
mismatch and red numbers indicate zones with a mismatch larger than the 1% threshold. (C) Differential
overlay (coronal view) of the raw image and the binarized neo-tissue with indication of the zones (green)
without mismatch between the raw and the binarized images and (red) where the 2-level segmentation
resulted in a mismatch between the raw and the binarized images. (D) The histogram showing the
mismatched area between the raw and the binarized images as indicated in (C). The grey striped line
indicates the 1% threshold above which a mismatch was considered. Scale bars are 1 mm.
doi:10.1371/journal.pone.0130227.g003
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histograms, the fraction of mismatched images was determined. In order to omit the influence
of background noise on the analysis, slides with a mismatch lower than 1% of the total slide
surface were excluded from the analysis.
Influence of the DoE parameters for PTA staining on the neo-tissue integrity. To first
evaluate the influence of both contrast agents on the neo-tissue integrity, a comparison be-
tween the datasets of constructs with and without staining was made. For the Ti6Al4V-based
TE constructs, visualization of the neo-tissue without contrast agent was not possible as the
scanning energies required to obtain sufficient transmission through the metal scaffold resulted
in greyscale values for the neo-tissue that could not be segmented from the background noise
and streaks. Therefore, PCL based TE constructs were used, as the lower X-ray opacity of PCL
enabled the visualization of the neo-tissue without the presence of a contrast agent. Differential
overlays of the datasets of TE constructs consecutively scanned (1) without contrast agent, (2)
with Hexabrix, (3) with PTA, (4) again with Hexabrix and finally (5) without contrast agent
were generated. The mismatch between the binarized neo-tissue for the different scans was de-
termined to evaluate the influence of the contrast agent on the tissue integrity, and the potential
staining-induced tissue shrinkage.
Then, as final DoE read-out, the influence of the PTA staining on the tissue integrity was de-
termined. This was quantified as the difference between the Hexabrix (Fig 4A) and PTA (Fig
4B) stained neo-tissue surface area relative to the Hexabrix stained neo-tissue surface area in
the corresponding CE-nanoCT slices. Hereto, the Hexabrix and PTA stained datasets of the
same sample were registered in 3D using DataViewer (Bruker MicroCT, Belgium). To avoid
the evaluation of mismatched slices, three transaxial slices per dataset, distributed over the
height of the TE construct, were selected. Using the optimal segmentation procedure for the
different contrast agents as described earlier, the neo-tissue was binarized applying CTAn
(Bruker MicroCT, Belgium). To reduce the errors introduced by the partial volume effect
(PVE) and metallic artifacts for analyzing the neo-tissue surface area, the binarized images for
the scaffold structure were dilated by 2 voxels and subtracted from the dataset of the binarized
neo-tissue. The noise in the binarized neo-tissue images was minimized by removing black and
Fig 4. Quantification of tissue shrinkage.Representative transaxial cross-sections of (A) a Hexabrix (60%,
240 min) stained TE construct and (B) the same TE construct stained with PTA (7.5%, 240 min). The insets
show the binarized images of the neo-tissue in the cross-section, based on which the surface area of neo-
tissue was calculated. Scale bar is 1 mm.
doi:10.1371/journal.pone.0130227.g004
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white speckle noise smaller than 200 voxels. In order to solidify the resulting structure, a ‘clos-
ing’ operation of 2 voxels was performed. Finally, the surface area of the binarized neo-tissue
was quantified and the degree of tissue shrinkage (i.e. inverse of the tissue integrity) was deter-
mined relative to the Hexabrix stained neo-tissue using Eq 2. The average neo-tissue thickness
was calculated on every CT slice using the 2D thickness analysis algorithm from CTAn (Bruker
MicroCT). Based on the 3D thickness analysis ona subsection without mismatch of the data-
sets, 3D color-coded rendering showing the neo-tissue thickness distribution were generated
using CTVox (Bruker MicroCT).
SAHex  SAPTA
SAHex
¼ degree of tissue shrinkage ð2Þ
where SAHex is the Hexabrix stained neo-tissue surface area and SAPTA is the PTA stained neo-
tissue surface area in the corresponding CE-nanoCT slice.
Results and Discussion
Image quality
As a DoE analysis read-out, the normalized contrast of the stained neo-tissue compared to the
background and scaffold was determined for each experimental condition. For both contrast
agents, the concentration was the most influencing parameter (Fig 5B and 5C). This could also
be observed from the raw data (Fig 5A), which showed a concentration-dependent increase in
relative contrast, independent of the staining time or neo-tissue volume.
Staining time did not significantly influence the normalized contrast, indicating that both
contrast agents had infiltrated the neo-tissue within 30 minutes, even for the largest neo-tissue
volume (Fig 5B and 5C). Although limitations in staining homogeneity and intensity due to
diffusion limitations of the contrast agent have been reported [22], these were not observed in
our experiments. Non-mineralized neo-tissue developed in a perfusion bioreactor system, such
as the neo-tissue in this study, was reported to have an approximate cell density of 6  106 cells/
cm3 [30, 36], while the density of native tissue, in which diffusion limitations were previously
reported, can on average be between 108 and 109 cells/cm3. Since no influence of the staining
time was observed within the operating window of our experiments, the lower cell density of
Fig 5. Influence of all DoE parameters on normalized contrast. (A) Normalized contrast difference
between neo-tissue and background as shown in Eq 1 for Hexabrix (black) and PTA (grey) for all conditions
of the DoE. Pareto charts for (B) Hexabrix and (C) PTA stained TE constructs, showing the ranking of the
influence of all staining parameters on normalized contrast. The dotted line indicates a significance level of
p = 0.05.
doi:10.1371/journal.pone.0130227.g005
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the engineered neo-tissues will enable both contrast agents to fully infiltrate within the minimal
staining time of 30 min.
For Hexabrix (Fig 5B), the normalized neo-tissue contrast was negatively influenced by the
neo-tissue volume. As shown in earlier work, the neo-tissue has a fibrous structure [37]. Due to
the limited spatial image resolution and the dense packing of the individual fibers (i.e. inter-
fiber distances below the spatial image resolution), they cannot be discriminated in the CE-
nanoCT images. Moreover, since Hexabrix is an equilibrium contrast agent, the staining solu-
tion might be entrapped between neo-tissue fibers during infiltration. For the high level of
neo-tissue volume, the neo-tissue fibers might be more densely packed and we could hypothe-
size that less volume is available within the porous neo-tissue for the Hexabrix solution to be
entrapped. As a result, the greyscale of the bulk neo-tissue will be lower compared to the less
packed neo-tissue for the low- and mid-level of neo-tissue volume. Consequently, the normal-
ized contrast of the neo-tissue is lower, as depicted in the pareto chart.
Dataset quality
Optimization of the image segmentation procedure. To quantitatively and objectively
evaluate which segmentation procedure was optimal for each contrast agent, the fraction of im-
ages containing a mismatch between the stained and the binarized neo-tissue fraction was de-
termined for datasets with low, mid and high levels of each DoE factor. Fig 6 indicates that
both for the Hexabrix and PTA stained ‘low-level’ constructs (low values of all 3 parameters),
binarization of the neo-tissue could not be done correctly, hence excluding automated analysis
of the neo-tissue volume for these conditions. Both for the Hexabrix-stained TE constructs
with a mid- and high-level parameter set, the 2-level Otsu segmentation enabled binarization
of the neo-tissue with a minor mismatch (Fig 6A), and was therefore further used for the evalu-
ation of the Hexabrix stained TE constructs. For the PTA stained TE constructs with a mid-
and high-level neo-tissue volume, all segmentation levels resulted in a high mismatch between
the stained and binarized neo-tissue fraction. No significant differences were observed between
the 3, 4 and 5-level segmented images (Fig 6B). However, the more levels that needed to be seg-
mented, the larger the processing time that was required to generate the segmented images.
Therefore a 3-level Otsu segmentation was used for further analysis of the PTA-stained
TE constructs.
Influence of DoE parameters on the dataset quality. To determine the influence of the
DoE parameters on the dataset quality, the fraction of slices with a mismatch between the
stained and binarized neo-tissue was evaluated using the optimized segmentation settings as
Fig 6. Percentage of mismatched slices for different Otsu segmentation levels and for all DoE
parameters. Percentage of slices of the full dataset showing a mismatch between the stained and binarized
neo-tissue for different Otsu segmentation levels and different value sets for all three DoE parameters (neo-
tissue volume, staining time and concentration) for (A) Hexabrix and (B) PTA stained TE constructs.
*p < 0.05.
doi:10.1371/journal.pone.0130227.g006
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described above. For both contrast agents, their concentration significantly influenced the frac-
tion of mismatched slices (Fig 7B and 7C). As the normalized contrast of neo-tissue increased
with increasing concentration, it could be more easily separated from the scaffold-dependent
image artifacts, and thus the amount of mismatched slices decreased significantly (Fig 7A).
Both contrast agents showed a high mismatch for low volumes of neo-tissue (Fig 7A). This
confirmed the findings from our previous study, where we determined the CE-nanoCT thresh-
old for neo-tissue quantification to be a neo-tissue volume lower than 4% of the total TE con-
struct void volume [21]. This lower quantification limit was directly related to the artifacts
introduced by the metallic scaffolds. The DoE analysis showed however that only in the case of
PTA the neo-tissue volume had a significant effect on the dataset quality, as an increase in neo-
tissue volume resulted in a significant decrease in mismatched slices (Fig 7C). This is mainly
caused by the neo-tissue structure, which for the low neo-tissue volume is on average much
thinner compared to the other levels of neo-tissue volume (Fig 8). When compared to the Hex-
abrix stained neo-tissue (Fig 8), the PTA stained neo-tissue showed for all experimental condi-
tions a more fibrous structure. Moreover its thickness could approach the spatial resolution of
the images (i.e. 7.5 μm–11.5 μm). Consequently, the PVE reduces the contrast of the neo-tissue,
making it no longer separable from the scaffold-dependent image artifacts. Additionally, when
the volume fraction of the bulk neo-tissue became too small, as was the case for the low neo-tis-
sue volume, its peak in the cross-section greyscale histogram could no longer be segmented
from the other phases in the images. The combination of the above mentioned factors all con-
tributed to the mismatch quantified in Fig 7.
Tissue integrity
Influence of the different contrast agents on the neo-tissue integrity. As mentioned ear-
lier, the use of PTA as a contrast agent can cause tissue shrinkage [24]. For Hexabrix, as this is
a clinically approved contrast agent that does not chemically bind to the tissue, no effect on the
tissue integrity was expected. To the best of our knowledge, there are no studies in the literature
that have reported an effect of Hexabrix staining on the tissue integrity. Using PCL-based TE
constructs without and with Hexabrix staining (Fig 9A and 9B respectively), we could confirm
this, as the PCL scaffolds allow us to visualize the neo-tissue without the use of a contrast
Fig 7. Influence of all DoE parameters on the mismatch between the stained and binarized neo-tissue.
(A) The percentage of slices with a mismatch between the stained and binarized neo-tissue for Hexabrix
(black) and PTA (grey) for all conditions of the DoE. (B, C) Pareto charts for Hexabrix (B) and PTA (C) stained
TE constructs respectively, showing the influence of the different staining parameters on the mismatch. The
dotted line indicates a significance level of p = 0.05.
doi:10.1371/journal.pone.0130227.g007
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agent. When overlaying both datasets (Fig 9E), the largest difference (indicated in black) was
the scaffold itself, since this could not be segmented from the neo-tissue in the images without
contrast agent. Some small differences (indicated in white) were found in the small pores,
where the Hexabrix solution might have been not removed during the short drying step prior
to scanning (on average 4.81 ± 3.95% of the total neo-tissue volume, n = 3). The viscosity of the
Hexabrix solution is higher than that of the PBS itself, causing a more difficult removal of the
liquid from the pores during the drying step. We could therefore conclude that the Hexabrix
staining does not influence the neo-tissue structure.
Fig 8. Morphology and thickness of the neo-tissue for different DoE conditions. (A-C) Representative
cross-sectional images and 3D color-coded renderings for TE constructs with (from left to right) low, medium
and high levels of neo-tissue volume, stained with 60% Hexabrix. (D-F) Representative cross-sectional
images and 3D color-coded renderings for TE constructs with (from left to right) low, medium and high levels
of neo-tissue volume, stained with 7.5% PTA. Scale bar is 1 mm. For each condition, the average neo-tissue
thickness is included (n = 3).
doi:10.1371/journal.pone.0130227.g008
Multifactorial Optimization of CE-CT to Quantify Neo-Tissue Formation
PLOS ONE | DOI:10.1371/journal.pone.0130227 June 15, 2015 12 / 17
Subsequent to the Hexabrix staining and an overnight rinsing step in PBS solution to re-
move the Hexabrix, TE constructs were stained with PTA and imaged again. A strong influence
on the neo-tissue integrity was appreciated (Fig 9C), and a clear difference with the Hexabrix
stained dataset was seen (Fig 9F). To confirm that this difference was due to the PTA staining,
the TE construct was once again stained with Hexabrix after overnight rinsing in PBS and
scanned (Fig 9D). Although the small pores were again filled with the Hexabrix solution as
mentioned earlier, a significant difference was seen compared to the first Hexabrix stained
dataset (up to 29 ± 17.5% of the total neo-tissue volume), indicating that the PTA staining in-
deed caused tissue shrinkage.
Influence of DoE parameters for PTA staining on the neo-tissue integrity. The degree
of tissue shrinkage due to PTA staining was quantified as the difference between the Hexabrix
and PTA stained neo-tissue surface area in the corresponding CE-nanoCT slices relative to the
Hexabrix stained neo-tissue surface area. In agreement with other studies [23, 24], the DoE
showed that the concentration of the contrast agents has the strongest effect on the tissue
shrinkage (Fig 10). Although an increase in the concentration caused a significant increase in
the normalized neo-tissue contrast (Fig 5C), as well as a significant decrease in the amount of
mismatched images (Fig 7C), it did introduce a significant tissue shrinkage. Hence, when accu-
rate neo-tissue morphometric analyses should be performed, the concentration should be kept
as low as possible. Additionally, also an increase in neo-tissue volume was shown to result in a
significant increase in tissue shrinkage, which could be expected as more neo-tissue is available
for the PTA to affect.
As the chemistry of the staining is not fully defined yet [23], we cannot give a clear explana-
tion for the tissue shrinkage. It has however been shown that tissue shrinkage because of the
contrast agents is strongly dependent on the tissue composition and structure, since a different
degree of shrinkage was found for different soft and mineralized tissue types [21, 23, 24]. As we
Fig 9. Influence of the different contrast agents on the neo-tissue integrity. (A) A typical transaxial
cross-section through a PCL-based TE construct without a contrast agent. The red arrow indicates the PCL
scaffold; the yellow arrow indicates the neo-tissue; the white arrow indicates the air space. The
corresponding binarized images for neo-tissue of the (B) Hexabrix (60%) stained dataset, (C) PTA (7.5%)
stained dataset after Hexabrix staining and (D) Hexabrix (60%) stained dataset after the consecutive
Hexabrix and PTA staining. (E) The differential overlay image of (A) and (B); (F) the differential overlay image
of (B) and (C); and (G) differential overlay image of (B) and (D). The black voxels in the overlay images
represent the voxels present in the first dataset, but not in the second; the white voxels represent the voxels
present in the second dataset, but not in the first. Scale bars are1 mm.
doi:10.1371/journal.pone.0130227.g009
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currently have no quantitative data on the composition or fibrous structure of the neo-tissue
for the different levels of neo-tissue volume, we cannot claim that this could influence the tissue
shrinkage. Histological sectioning would have enabled us to confirm the fibrous structure of
the neo-tissue. Although we did attempt to make histological sections of the PCL scaffolds post
scanning using various embedding techniques such as paraffin, OCT (optimal cutting tempera-
ture compound) and PMMA (polymethylmethacrylate) embedding, this was without success.
Sectioning of these constructs resulted in severe cutting artifacts, which made histological anal-
ysis of neo-tissue structure impossible. We did however show using CE-nanoCT that the bulk
neo-tissue structure for the low-level neo-tissue volume was much thinner than for the mid-
and high-level neo-tissue volume. As a result, the segmentation and binarization of the neo-tis-
sue was less accurate (Fig 7). Because of this, and due to the influence of the PVE, the calcula-
tion of the degree of tissue shrinkage for the low-level of the neo-tissue volume might be
inaccurate and should be evaluated with care.
Conclusions
Using a DoE approach, we were able to provide the most optimal staining conditions for CE-
nanoCT of neo-tissue in Ti6Al4V scaffolds by quantifying and ranking in statistical importance
the factors that influence the CE-nanoCT staining procedure using Hexabrix and PTA. These
factors were contrast agent concentration, staining time and the presence of neo-tissue (vol-
ume). Their effect on image quality, dataset quality and tissue integrity was investigated.
For Hexabrix staining of the neo-tissue in Ti alloy scaffolds, in this study the most optimal
staining conditions were (i) a concentration of 60% (vol% in PBS) and (ii) a staining time of 30
minutes. These were sufficient to allow accurate and fully automated quantification of the neo-
tissue formed. When the neo-tissue volume fraction was however less than 4% of the open
space, in this study represented by the low-level neo-tissue volume, quantitative analysis of the
datasets was not possible.
For PTA staining, the DoE showed that in this study a high concentration was necessary for
sufficient image contrast and accurate, automated 2D/3D image analysis, although significant
tissue shrinkage was introduced. Hence, based on the results from the DoE, for this study we
concluded using only 2.5% (weight% in PBS) of PTA. As the staining time did not have any sig-
nificant influence, this was kept as low as possible (in this case 30 minutes).
Fig 10. Influence of the DoE parameters for PTA staining on the neo-tissue integrity. Pareto chart for
the PTA-stained TE constructs when evaluating the degree of tissue shrinkage. The dotted line indicates a
significance level of p = 0.05.
doi:10.1371/journal.pone.0130227.g010
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As a result of this study, and by using a DoE approach to optimize the staining conditions,
we have converted CE-nanoCT into a quantitative and 3D measuring tool to evaluate neo-tis-
sue formation in TE constructs and its spatial distribution.
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